Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
KeyBanc Capital Markets increased its price target on Parker-Hannifin to $1,100 from $1,050 and kept an Overweight rating following the company's fiscal second-quarter 2026 results. The move reflects what the firm described as continued strong execution against a choppy end-market backdrop outside aerospace, with the company reporting adjusted Q2 E…
KeyBanc Capital Markets left its Sector Weight rating on Apple following the company’s fiscal first-quarter 2026 report, citing strong operational results but a valuation it views as full and expectations for slower growth. The quarter delivered sizable iPhone revenue gains, earnings-per-share acceleration and guidance above consensus, while margin…
KeyBanc Capital Markets raised its price target on ResMed to $302 from $299 and kept an Overweight rating after the company's fiscal second-quarter 2026 results. The firm cited revenue outperformance led by Masks & Accessories and Devices, an improved gross margin outlook, and a robust balance sheet. ResMed reported EPS of $2.81 versus $2.73 expect…
Canada's real gross domestic product was essentially flat in November after a 0.3% decline in October, as a 1.3% fall in manufacturing and a 2.1% drop in wholesale trade offset expansions in retail sales, public sector activity and transportation. Early December data point to a 0.1% rise, but the quarter likely recorded a 0.1% contraction, leaving …
This report catalogues the most notable insider transactions disclosed on Thursday, January 29, 2026. Key highlights include a large purchase by a USA Rare Earth director, additional buys by company insiders and large shareholders at Under Armour and ASA Gold & Precious Metals Ltd, and sizeable sales by executives at Microchip Technology, Micro…
Parke Bancorp President and CEO Pantilione Vito S. bought 1,000 shares of common stock on January 29, 2026, at $27.63 per share for a total of $27,630. The purchase increases his direct shareholdings and sits alongside a portfolio of indirect holdings, options and restricted stock units. Separately, the New Jersey-based bank announced a $0.18 per-s…
Morgan Stanley reduced its price target on Lennox International to $450 from $475 and kept an Underweight rating following the company’s Q4 2025 results. The firm pointed to ongoing volume softness, weak end-market demand, under-absorption risk and pricing pressure as drivers for the lower valuation. Morgan Stanley’s forecasts for 2026 and Q1 2026 …
Keefe, Bruyette & Woods trimmed its 12-month price target for Progressive Corp. to $225 from $252, a 10.7% reduction, while retaining a Market Perform rating. KBW analyst Meyer Shields cited moderating auto policies in force as the primary driver of the revision. The move comes amid a range of analyst views on Progressive, including recent actions …
Keefe, Bruyette & Woods raised its price target on Civista Bancshares to $28 from $27 and retained an Outperform rating after the bank posted stronger-than-expected fourth-quarter operating results and reported higher reported EPS and revenue. The research firm noted benefits across core revenue lines and a slimmer-than-anticipated provision, while…
Stifel has downgraded Unite Group (UTG) from Buy to Hold and reduced its price objective to 600p from 975p, citing weaker-than-expected sales momentum for the upcoming academic year and lower occupancy assumptions after the Empiric acquisition. The broker expects limited dividend growth over its forecast period and models the shares trading at a 6.…
Kepler Cheuvreux has moved Derwent London from Buy to Hold while retaining a 2,050p price target. The broker pointed to a 17% share rally since September and the uncertainty created by the company's announced CEO retirement as reasons for the downgrade. Kepler kept its forecasts and target methodology unchanged, noting limited upside from the curre…
Atlanta Fed President Raphael Bostic told CNBC that the Federal Reserve should adopt a patient stance on interest rates while remaining alert to inflationary pressures. He said there are "ways to go on inflation," expects tariff impacts to show up in the first half of 2026, and wants clear evidence of a return to 2% inflation before altering policy…
Bernstein increased its price target on IBM to $330 from $280 and kept a Market Perform rating after stronger-than-expected fourth-quarter results. IBM exceeded consensus on revenue, earnings per share and free cash flow, provided FY26 guidance that includes more than 5% constant-currency revenue growth and forecasted margin and cash-flow improveme…
Bernstein SocGen Group lowered its price target on United Rentals (URI) to $965 from $1,128 and kept an Outperform rating after the company reported fourth-quarter EBITDA that was slightly below expectations and issued 2026 EBITDA guidance below consensus. Investors focused on sustained margin compression, driving a sharp share decline, even as val…
Bernstein SocGen has reaffirmed an Outperform rating and a $405.00 price target on UnitedHealth Group (UNH) after the shares plunged about 20% in the wake of Medicare Advantage advance rate announcements and the company’s fourth-quarter results. Analyst Lance Wilkes outlined five principal investor concerns, and Bernstein adjusted its model to acco…
Bernstein raised its 12-month price target on RTX Corp. to $204 from $189 while retaining a Market Perform designation, pointing to stronger-than-expected results in the Raytheon segment. RTX recently posted quarterly and full-year beats, a rising backlog at Raytheon and several sizable contract awards, but the firm signaled ongoing concerns around…
Molina Healthcare ($MOH) sold off after CMS proposed a 0.09% Medicare Advantage rate increase for 2027 on 01/27/2026. The pullback creates a mid-term swing entry into a company with a $9.5B market cap, P/E near 11, and deep Medicaid exposure (roughly 75% of revenue). We recommend buying the dip with a clear entry, stop and target and a 45-trading-d…
Bernstein increased its price target for Deckers Outdoor to $90 from $85 while retaining an Underperform rating following a third quarter that beat sales and margin expectations. Deckers reported EPS of $3.33 and revenue of $1.96 billion for fiscal Q3 2026, prompting other firms to raise targets even as Bernstein cautions on soft Q4 guidance for Ug…
Bernstein SocGen Group increased its price target on Caterpillar to $678 from $630 while retaining a Market Perform rating. The move follows a robust fourth-quarter showing and indicators of strengthening demand, but the firm warns the stock trades at a valuation well above typical peaks, leaving upside tied to execution on pricing and tariff relie…
Wolfe Research upgraded Broadcom to Outperform and set a $400 price target after its checks pointed to rapid growth in Google's TPU program and related custom silicon demand. The firm boosted revenue and EPS forecasts for 2027 and raised near-term AI ASIC and networking estimates, while leaving non-AI semiconductor and infrastructure software proje…
Bernstein SocGen has maintained an Outperform rating on Netflix with a $115 price target, implying roughly 38% upside from the stock's current level. The firm highlights attractive entry levels after the company’s fourth-quarter results, while flagging three unresolved overhangs that will affect returns. The proposed $83 billion bid for Warner Bros…
Lucid Capital Markets downgraded Quince Therapeutics Inc. (QNCX) from Buy to Sell and removed its price target after the company announced that its pivotal Phase 3 NEAT trial failed to meet both primary and key secondary endpoints. The trial miss, the decision to discontinue the program that represented Quince’s sole development asset, and the comp…
India’s economy is expected to expand above 7% this fiscal year, yet the chief economic adviser warned that global macroeconomic uncertainty and sustained financial market corrections could push growth toward the lower bound of official projections. The finance ministry’s economic survey projects 6.8% to 7.2% growth for the next fiscal year and rai…
Citi upgraded Spotify to a Buy rating and maintained a $650 price target, arguing the streaming company’s shares are undervalued relative to 2027 free cash flow metrics. Analyst Jason Bazinet says Citi expects Spotify to outpace Wall Street revenue and adjusted EBITDA forecasts, driven by slightly stronger Premium average revenue per user and margi…
AstraZeneca has obtained global rights (excluding certain Chinese territories) to several of CSPC Pharmaceutical Group's experimental obesity therapies under a deal that carries $1.2 billion in upfront consideration and up to $17.3 billion in milestone payments. The agreement expands an existing collaboration between the two firms, covers developme…
